top of page
Search
Writer's pictureAbacus Research

Entegris (ENTG): Under-appreciated compounder

Entegris is a chemicals and filtration company that just happens to sell into the semiconductor market. We want to be owners of ENTG as it is high-quality, defensive, and an EPS compounder that will out-grow semi volume growth due to trends of increasing purity and material intensity in semis.

  • We think the benefits from the CMC acquisition could surprise on the upside and is not fully appreciated by the market.

  • Financials are poised to improve: EPS growth will accelerate meaningfully in late 2023 driven by revenue growth, high incremental margins, cost saves, and continue into 2025 as debt is paid down.

Potential Upside: $114 (+31%) Sensible Downside: $70 (-20%)


Recent Posts

See All

CBRE: EPS has bottomed

We like the commercial real estate brokers as a way to play expected normalizing in the CRE market aided by falling rates Q2’24 was the...

Comentários


bottom of page